Breast carcinomas: variations in sonoelastographic appearance

Código QR

Breast carcinomas: variations in sonoelastographic appearance

Eduardo de Faria Castro Fleury,1 Maria do Carmo Guedes Alcoforado Assunção-Queiros,2 Decio Roveda Jr1 1Faculdade de Cências Médicas da Santa Casa de São Paulo, São Paulo, Brazil; 2Faculdade de Medicina da Universidade de Sã...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fleury E, Assunção-Queiroz M, Roveda Jr D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/2850d9f9a2f141079990a8cb9391b3e2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

In vitro human skin permeation of endoxifen: potential for local transdermal therapy for primary prevention and carcinoma in situ of the breast
por: Lee O, et al.
Publicado: (2011)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Willard Wong, et al.
Publicado: (2021)

Silicone-induced granuloma of breast implant capsule (SIGBIC): similarities and differences with anaplastic large cell lymphoma (ALCL) and their differential diagnosis
por: Fleury EF, et al.
Publicado: (2017)

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
por: Mathilde M. M. Almekinders, et al.
Publicado: (2021)

Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation
por: Kang Wang, et al.
Publicado: (2021)

Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma
por: Mary Kathryn Abel, et al.
Publicado: (2021)

Next-generation sequencing revealed recurrent ZFPM1 mutations in encapsulated papillary carcinoma of the breast
por: Xuguang Liu, et al.
Publicado: (2021)

Breast reconstruction: current and future options
por: Paul Jr H, et al.
Publicado: (2011)

RIPK1 is a negative mediator in Aquaporin 1-driven triple-negative breast carcinoma progression and metastasis
por: Zhuming Yin, et al.
Publicado: (2021)

Genetic mutation and biological pathway prediction based on whole slide images in breast carcinoma using deep learning
por: Hui Qu, et al.
Publicado: (2021)

Automated percent mammographic density, mammographic texture variation, and risk of breast cancer: a nested case-control study
por: Erica T. Warner, et al.
Publicado: (2021)

Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysis
por: Dómhnall J. O'Connor, et al.
Publicado: (2022)

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
por: Tom Walsh, et al.
Publicado: (2021)

Identification of genes involved in breast cancer and breast cancer stem cells
por: Apostolou P, et al.
Publicado: (2015)

Dormancy in breast cancer
por: Banys M, et al.
Publicado: (2012)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
por: Nehmat Houssami
Publicado: (2021)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
por: Jennifer Xiao, et al.
Publicado: (2021)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Thomas P. Slavin, et al.
Publicado: (2017)

Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
por: Allan Lipton
Publicado: (2011)

Sonomammographic characteristics of invasive lobular carcinoma
por: El-Damshety O, et al.
Publicado: (2012)

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
por: Sasha E. Stanton, et al.
Publicado: (2021)

The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease
por: Francisco Beca, et al.
Publicado: (2021)

An alternative model for (breast) cancer predisposition
por: Erik Teugels, et al.
Publicado: (2017)

Current strategies for the prevention of breast cancer
por: Advani P, et al.
Publicado: (2014)

Optical imaging for breast cancer prescreening
por: Godavarty A, et al.
Publicado: (2015)

The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
por: Marion Maetens, et al.
Publicado: (2017)

Comprehensive molecular profiling of pulmonary pleomorphic carcinoma
por: Masaaki Nagano, et al.
Publicado: (2021)

Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)
por: Yongxian Zhuang, et al.
Publicado: (2021)

Breast cancer in Brazil: epidemiology and treatment challenges
por: Cecilio AP, et al.
Publicado: (2015)

Tamoxifen for women at high risk of breast cancer
por: Nazarali SA, et al.
Publicado: (2014)

A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012)

Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)

Taxanes in the elderly patient with metastatic breast cancer
por: Yardley DA
Publicado: (2015)

Hypofractionated whole breast radiotherapy: current perspectives
por: Koulis TA, et al.
Publicado: (2015)

Breast cancers are rare diseases—and must be treated as such
por: John M. S. Bartlett, et al.
Publicado: (2017)

Benefits of multidisciplinary teamwork in the management of breast cancer
por: Taylor C, et al.
Publicado: (2013)

Emerging targeted combinations in the management of breast cancer
por: Lee RJ, et al.
Publicado: (2013)

Immunotherapy in breast cancer: A clinician's perspective
por: Sibapriya Chaudhuri, et al.
Publicado: (2021)

Targeting &gamma;-secretase in breast cancer
por: Han J, et al.
Publicado: (2012)

Multidrug-resistant breast cancer: current perspectives
por: Martin HL, et al.
Publicado: (2014)